UBS Group’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $442K | Buy |
44,288
+18,028
| +69% | +$180K | ﹤0.01% | 4940 |
|
|
2025
Q1 | $157K | Sell |
26,260
-66,901
| -72% | -$399K | ﹤0.01% | 5467 |
|
|
2024
Q4 | $715K | Buy |
93,161
+49,396
| +113% | +$379K | ﹤0.01% | 4470 |
|
|
2024
Q3 | $447K | Buy |
43,765
+14,379
| +49% | +$147K | ﹤0.01% | 4175 |
|
|
2024
Q2 | $436K | Sell |
29,386
-29,708
| -50% | -$441K | ﹤0.01% | 4016 |
|
|
2024
Q1 | $806K | Buy |
59,094
+13,810
| +30% | +$188K | ﹤0.01% | 3702 |
|
|
2023
Q4 | $496K | Buy |
45,284
+22,158
| +96% | +$243K | ﹤0.01% | 3982 |
|
|
2023
Q3 | $253K | Sell |
23,126
-21,589
| -48% | -$236K | ﹤0.01% | 4107 |
|
|
2023
Q2 | $592K | Buy |
44,715
+1,068
| +2% | +$14.1K | ﹤0.01% | 3692 |
|
|
2023
Q1 | $594K | Sell |
43,647
-47,218
| -52% | -$643K | ﹤0.01% | 3581 |
|
|
2022
Q4 | $1.77M | Buy |
90,865
+23,027
| +34% | +$450K | ﹤0.01% | 2662 |
|
|
2022
Q3 | $1.29M | Sell |
67,838
-90,366
| -57% | -$1.72M | ﹤0.01% | 2665 |
|
|
2022
Q2 | $3.26M | Sell |
158,204
-12,486
| -7% | -$257K | ﹤0.01% | 2060 |
|
|
2022
Q1 | $5.49M | Buy |
170,690
+132,934
| +352% | +$4.28M | ﹤0.01% | 1851 |
|
|
2021
Q4 | $1.76M | Buy |
37,756
+37,621
| +27,867% | +$1.75M | ﹤0.01% | 2974 |
|
|
2021
Q3 | $4K | Sell |
135
-2,749
| -95% | -$81.5K | ﹤0.01% | 7496 |
|
|
2021
Q2 | $74K | Sell |
2,884
-9,641
| -77% | -$247K | ﹤0.01% | 5053 |
|
|
2021
Q1 | $428K | Buy |
12,525
+8,919
| +247% | +$305K | ﹤0.01% | 4042 |
|
|
2020
Q4 | $122K | Buy |
+3,606
| New | +$122K | ﹤0.01% | 4579 |
|